Hepatic steatosis has no effect in diagnosis accuracy of LI-RADS v2018 categorization of hepatocellular carcinoma in MR imaging
Journal of Magnetic Resonance Imaging Jun 17, 2021
Yao S, Wei Y, Ye Z, et al. - A prospective study was conducted to explore and compare the differences in hepatocellular carcinoma (HCC) related imaging features between with- and without-hepatic steatosis (HS) groups, and to further determine whether HS affects the diagnosis accuracy of Liver Imaging Reporting and Data System (LI-RADS) v2018 of HCC in MRI. Researchers enrolled a total of 171 patients (mean age, 52 ± 11 years; range, 26–83 years) including 137 men and 34 women. Individuals were categorized as HS and non-HS groups according to MRI-proton density fat-fraction (PDFF). The results of this study demonstrate that diagnosis of HCC based on LI-RADS v2018 in MRI is of comparable performance regardless of HS, in which there is no significant difference in either the major imaging features or LR categorization.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries